Literature DB >> 17146670

Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis.

Asiri S Abeyagunawardena1, Neil J Sebire, R Anthony Risdon, Michael J Dillon, Lesley Rees, William Van't Hoff, Pallegoda V Kumarasiri, Richard S Trompeter.   

Abstract

Clinical and histological data of children presenting with steroid-resistant nephrotic syndrome and renal biopsy showing focal and segmental glomerulosclerosis from 1980 with a follow-up of over 10 years were reviewed. There were 66 patients; 38 male and 28 female. Age at onset ranged from 0.4-14.1 years (mean 6.4). Tubular atrophy was present at first biopsy in 50/66, capsular adhesions in 35/66, glomerular tip lesions in 8/66 and mesangial expansion in 31/66 patients. In 51 children, cyclophosphamide was prescribed as the first cytotoxic agent, while 15 received cyclosporine A and complete remission was induced in 43 and 40% of the children, respectively. Complete and stable remission was maintained in 35 children, while 22 had reduction of proteinuria with symptomatic relief. Nine were refractory to cytotoxic therapy. Of the 35 patients who entered complete and stable remission, the renal survival was over 90%, while in the 31 non-responders it was 48% in 10 years. The multivariate analysis using unconditional logistic regression method identified the presence of mesangial expansion (p=0.011) and tip lesions (p=0.005) as the independent predictors of favourable response to cytotoxic therapy and the presence of renal impairment (p=0.008) and extensive focal segmental sclerosis (p=0.025) as independent predictors of unfavourable response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146670     DOI: 10.1007/s00467-006-0264-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

1.  Clinicopathological study of nephrotic syndrome in childhood.

Authors:  R H White; E F Glasgow; R J Mills
Journal:  Lancet       Date:  1970-06-27       Impact factor: 79.321

Review 2.  Immunosuppressive therapy of childhood idiopathic nephrotic syndrome.

Authors:  A Abeyagunawardena; Paul A Brogan; R S Trompeter; Matthew J Dillon
Journal:  Expert Opin Pharmacother       Date:  2002-05       Impact factor: 3.889

3.  Molecular basis of steroid-resistant nephrotic syndrome.

Authors:  C Antignac
Journal:  Nefrologia       Date:  2005       Impact factor: 2.033

Review 4.  Genetic forms of nephrotic syndrome.

Authors:  Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

5.  Primary focal segmental glomerulosclerosis in children: prognostic factors.

Authors:  R Martinelli; A S Okumura; L J Pereira; H Rocha
Journal:  Pediatr Nephrol       Date:  2001-08       Impact factor: 3.714

6.  One-center experience with cyclosporine in refractory nephrotic syndrome in children.

Authors:  A Singh; C Tejani; A Tejani
Journal:  Pediatr Nephrol       Date:  1999-01       Impact factor: 3.714

7.  The long-term prognosis of patients with focal segmental glomerulosclerosis.

Authors:  J S Cameron; D R Turner; C S Ogg; C Chantler; D G Williams
Journal:  Clin Nephrol       Date:  1978-12       Impact factor: 0.975

8.  Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up.

Authors:  B M Tune; R Kirpekar; R K Sibley; V M Reznik; W R Griswold; S A Mendoza
Journal:  Clin Nephrol       Date:  1995-02       Impact factor: 0.975

9.  The natural history of focal segmental glomerulosclerosis with and without mesangial hypercellularity in children.

Authors:  M J Schoeneman; B Bennett; I Greifer
Journal:  Clin Nephrol       Date:  1978-02       Impact factor: 0.975

10.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome.

Authors:  M Kestilä; U Lenkkeri; M Männikkö; J Lamerdin; P McCready; H Putaala; V Ruotsalainen; T Morita; M Nissinen; R Herva; C E Kashtan; L Peltonen; C Holmberg; A Olsen; K Tryggvason
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

View more
  21 in total

Review 1.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

Review 2.  New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.

Authors:  Michael van Husen; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2011-01-13       Impact factor: 3.714

Review 3.  Problems with 'focal segmental glomerulosclerosis'.

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

4.  Focal and segmental glomerulosclerosis in children: a longitudinal assessment.

Authors:  Olivia Boyer; Janelle K Moulder; Michael J G Somers
Journal:  Pediatr Nephrol       Date:  2007-04-17       Impact factor: 3.714

5.  Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children.

Authors:  Agnes Trautmann; Sven Schnaidt; Beata S Lipska-Ziętkiewicz; Monica Bodria; Fatih Ozaltin; Francesco Emma; Ali Anarat; Anette Melk; Marta Azocar; Jun Oh; Bassam Saeed; Alaleh Gheisari; Salim Caliskan; Jutta Gellermann; Lina Maria Serna Higuita; Augustina Jankauskiene; Dorota Drozdz; Sevgi Mir; Ayse Balat; Maria Szczepanska; Dusan Paripovic; Alexandra Zurowska; Radovan Bogdanovic; Alev Yilmaz; Bruno Ranchin; Esra Baskin; Ozlem Erdogan; Giuseppe Remuzzi; Agnieszka Firszt-Adamczyk; Elzbieta Kuzma-Mroczkowska; Mieczyslaw Litwin; Luisa Murer; Marcin Tkaczyk; Helena Jardim; Anna Wasilewska; Nikoleta Printza; Kibriya Fidan; Eva Simkova; Halina Borzecka; Hagen Staude; Katharina Hees; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

6.  Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study.

Authors:  Djalila Mekahli; Aurelia Liutkus; Bruno Ranchin; Anchalee Yu; Lucie Bessenay; Eric Girardin; Rita Van Damme-Lombaerts; Jean-Bernard Palcoux; François Cachat; Marie-Pierre Lavocat; Guylhène Bourdat-Michel; François Nobili; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

Review 7.  Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children.

Authors:  Jochen H H Ehrich; Lars Pape; Mario Schiffer
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

8.  Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.

Authors:  Yuko Hamasaki; Norishige Yoshikawa; Hitoshi Nakazato; Satoshi Sasaki; Kazumoto Iijima; Koichi Nakanishi; Takeshi Matsuyama; Kenji Ishikura; Shuichi Ito; Tetsuji Kaneko; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2013-01-13       Impact factor: 3.714

9.  Glomerular tip changes in childhood minimal change nephropathy.

Authors:  Alexander J Howie; Anju Agarwal; Neil J Sebire; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

10.  Therapies for steroid-resistant nephrotic syndrome.

Authors:  Elisabeth M Hodson; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2008-03-27       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.